日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial

CPX-351 与柔红霉素、阿糖胞苷和吉妥珠单抗治疗老年非不良风险 AML 患者的疗效比较:NCRI AML18 试验

Knapper, Steven; Dillon, Laura W; Babu, Malavika; Thomas, Abin; Thomas, Ian; Hourigan, Christopher S; Andrew, Georgia; Dillon, Richard; Gilkes, Amanda; Marquez Almuina, Nuria; King, Sophie; McCarthy, Nicholas; Bahr, Reem; Al-Ali, Rasha W; Stone, Louisa; Coats, Tom; Byrne, Jennifer; Green, Simone; Overgaard, Ulrik Malthe; Sellar, Rob S; Dennis, Mike; Mehta, Priyanka; Hills, Robert; Freeman, Sylvie D; Russell, Nigel H

Differences in cynomolgus macaque populations used for infectious disease research

用于传染病研究的食蟹猴种群的差异

Quist, Darcy; Ebisine, Kimimuepigha; Kennedy, Emma; Dowall, Stuart; Dennis, Mike

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

根据老年 AML 患者的残余疾病状态,采用氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和伊达比星,或克拉屈滨联合柔红霉素和阿糖胞苷强化治疗:来自 NCRI AML18 试验的结果

Russell, Nigel H; Thomas, Abin; Hills, Robert K; Thomas, Ian; Gilkes, Amanda; Almuina, Nuria Marquez; Burns, Sarah; Marsh, Lucy; Vyas, Paresh; Metzner, Marlen; McCarthy, Nicholas; Andrew, Georgia; Byrne, Jennifer; Sellar, Rob S; Kelly, Richard; Cahalin, Paul; Overgaard, Ulrik Malthe; Mehta, Priyanka; Dennis, Mike; Knapper, Steven; Freeman, Sylvie D

Safety and efficacy of combining midostaurin and gemtuzumab ozogamicin with induction chemotherapy in FLT3-mutated AML

在FLT3突变型急性髓系白血病(AML)中,米哚妥林联合吉妥珠单抗奥佐米星治疗并进行诱导化疗的安全性和有效性研究

Russell, Nigel; Othman, Jad; Cumming, Oliver; Thomas, Abin; Tedjaseputra, Aditya; Potter, Nicola; Jovanovic, Jelena; Gilkes, Amanda; Batten, Leona; Canham, Joanna; Hinson, Emily; Runglall, Manohursingh; Aucken, Phoebe; Kottaridis, Panos; Cavenagh, Jamie; Arnold, Claire; Freeman, Sylvie; Dennis, Mike; Knapper, Steven; Dillon, Richard

Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

急性髓系白血病患者的健康状况评估:欧洲白血病网络专家组的建议

Venditti, Adriano; Palmieri, Raffaele; Maurillo, Luca; Röllig, Christoph; Wierzbowska, Agnieszka; de Leeuw, David; Efficace, Fabio; Curti, Antonio; Ngai, Lok Lam; Tettero, Jesse; Adès, Lionel; Almeida, Antonio; Bullinger, Lars; Dennis, Mike; Esteve, Jordi; Ferrara, Felicetto; Heuser, Michael; Huls, Gerwin; Lübbert, Michael; Mehta, Priyanka; Montesinos, Pau; Pabst, Thomas; Récher, Christian; Rossi, Giuseppe; Russell, Nigel; Sierra, Jorge; Stauder, Reinhard; Vey, Norbert; Walter, Roland B; Wang, Eunice; Nier, Samantha; Martins, Carolina Garcez; Ossenkoppele, Gert

A revised prognostic model for patients with acute myeloid leukemia and first relapse

急性髓系白血病首次复发患者的修订预后模型

van der Maas, Niek G; Breems, Dimitri; Klerk, Clara P W; Pabst, Thomas; Gradowska, Patrycja; Thomas, Abin; Biemond, Bart J; Kuball, Jurgen; Van Elssen, Catharina H M J; Visser, Otto; Vekemans, Marie-Christiane; Graux, Carlos; Maertens, Johan; Knapper, Steven; Dennis, Mike; Freeman, Sylvie; Thomas, Ian; Beverloo, H Berna; Huls, Gerwin; Craddock, Charles; Valk, Peter J M; Vyas, Paresh; Russell, Nigel; Ossenkoppele, Gert; Löwenberg, Bob; Cornelissen, Jan J; Versluis, Jurjen

Feasibility and Acceptability of SARS-CoV-2 Antigen Rapid Diagnostic Testing in High-Risk Markets and Trade Hubs in Kampala, Uganda

在乌干达坎帕拉高风险市场和贸易中心开展SARS-CoV-2抗原快速诊断检测的可行性和接受度

Ssewanyana, Isaac; Acellam, Sam; Ampumuza, Martha; Nansumba, Hellen; Nabadda, Susan; Kushemererwa, Grace; Bigira, Victor; Zalwango, Sarah; Oundo, Chris; Walyomo, Richard; Chebrot, Isaiah; Buluma, Dennis Mike; Ndyabakira, Alex; Dani, Pallavi; Hoppe, Anne

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和伊达比星联合吉妥珠单抗可改善年轻新诊断急性髓系白血病患者的无事件生存期,并改善携带NPM1和FLT3突变患者的总生存期。

Russell, Nigel H; Wilhelm-Benartzi, Charlotte; Othman, Jad; Dillon, Richard; Knapper, Steven; Batten, Leona M; Canham, Joanna; Hinson, Emily L; Betteridge, Sophie; Overgaard, Ulrik Malthe; Gilkes, Amanda; Potter, Nicola; Mehta, Priyanka; Kottaridis, Panagiotis; Cavenagh, Jamie; Hemmaway, Claire; Arnold, Claire; Freeman, Sylvie D; Dennis, Mike

Risk Stratification in Older Intensively Treated Patients With AML

老年急性髓系白血病患者接受强化治疗的风险分层

Versluis, Jurjen; Metzner, Marlen; Wang, Ariel; Gradowska, Patrycja; Thomas, Abin; Jakobsen, Niels Asger; Kennedy, Alison; Moore, Rachel; Boertjes, Emma; Vonk, Christian M; Kavelaars, Francois G; Rijken, Melissa; Gilkes, Amanda; Schwab, Claire; Beverloo, H Berna; Manz, Markus; Visser, Otto; Van Elssen, Catharina H M J; de Weerdt, Okke; Tick, Lidwine W; Biemond, Bart J; Vekemans, Marie-Christiane; Freeman, Sylvie D; Harrison, Christine J; Cook, Jonathan A; Dennis, Mike; Knapper, Steven; Thomas, Ian; Craddock, Charles; Ossenkoppele, Gert J; Löwenberg, Bob; Russell, Nigel; Valk, Peter J M; Vyas, Paresh

Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy

现代诱导治疗后复发或难治性FLT3突变型急性髓系白血病患者接受单药吉瑞替尼治疗的疗效

Othman, Jad; Hwang, Angela; Brodermann, Maximillian; Abdallah, Islam; McCloskey, Kayleigh; Gallipoli, Paolo; Clarke, Georgina; Dang, Raymond; Vidler, Jennifer; Krishnamurthy, Pramila; Basheer, Faisal; Latif, Anne-Louise; Palanicawandar, Renuka; Taylor, Tom; Khan, Asra; Campbell, Victoria; Hogan, Francesca; Kanellopoulos, Alex; Fleming, Kathryn; Collins, Angela; Dalley, Chris; Loke, Justin; Marshall, Scott; Taussig, David; Munisamy, Sreetharan; Loizou, Eleana; Yassin, Heba; Dennis, Mike; Zhao, Rui; Belsham, Edward; Murray, Duncan; Fowler, Nicole; O'Nions, Jenny; Khan, Anjum; Sellar, Rob; Dillon, Richard